More IDO Issues: NewLink Drops Pancreatic Cancer Indication For Indoximod

 
• By Lucie Ellis-Taitt
  
Juggling
NewLink juggles too many indoximod options; drops pancreatic cancer program • Source: Shutterstock

More from Immuno-oncology

More from Anticancer